Alterations in the expression of prostate cancer marker candidate genes TMPRSS2-ERG (transmembrane protease, serine 2; ETV-related gene) and PCA3 (prostate cancer antigen 3) have previously been detected by us and others [5–9]. The gene discussed is ERG; the disease is prostate carcinoma.